NDA vs BLA: FDA Drug Approval Pathways Explained
Bringing a new therapy to market in the United States is a highly complex process that requires careful scientific, regulatory, and commercial planning. One of the most important early decisions in drug development is determining whether a product should follow the New Drug Application (NDA) pathway or the Biologics License Application (BLA) pathway. While the distinction may appear...
0 Commentarii 0 Distribuiri 9 Views 0 previzualizare
Sponsor